Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris global luxury conglomerate (EPA: MC) at ~€84.7B 2024 revenue; 75+ brands (Louis Vuitton, Dior, Hennessy, Sephora), named preferred buyer for Giorgio Armani (€10B+) after founder's Sept 2025 death, competing with Kering and Hermès.
LVMH Moët Hennessy Louis Vuitton SE is a Paris, France-based global luxury goods conglomerate — publicly traded on Euronext Paris (EPA: MC) and the world's largest luxury company by revenue — owning and managing 75+ prestige brands across Fashion & Leather Goods, Wines & Spirits, Perfumes & Cosmetics, Watches & Jewelry, and Selective Retailing through approximately 213,000 employees serving luxury consumers across 6 continents. LVMH's flagship brands include Louis Vuitton (the world's most valuable luxury brand), Christian Dior Couture, Moët & Chandon, Dom Pérignon, Hennessy cognac, Givenchy, Celine, Fendi, Bulgari, TAG Heuer, Hublot, Sephora, and DFS. In fiscal year 2024, LVMH reported revenue of approximately €84.7 billion, with the Fashion & Leather Goods segment (Louis Vuitton and Dior, ~40% of revenue) demonstrating resilience in a challenging global luxury environment characterized by post-pandemic demand normalization, Chinese luxury consumer caution, and currency headwinds. CEO and Chairman Bernard Arnault — the world's wealthiest individual — has built LVMH through decades of acquisitions of trophy luxury brands. LVMH's most significant strategic development for 2025-2026 is the preferred buyer designation for Giorgio Armani following the Italian fashion designer's death in September 2025 — with LVMH named in Armani's will as the preferred acquirer of the €10B+ Armani Group, with an initial 15% purchase within 18 months potentially leading to a full acquisition of one of the world's last independent luxury fashion houses.
Cloud Veterinary Practice Management & Client Engagement
Cloud vet practice management acquired by IDEXX; Auckland New Zealand; 5,000+ clinics in US, Australia, NZ, and UK; covers patient check-in through invoicing and end-of-day reconciliation.
ezyVet is a cloud-based veterinary practice management and client engagement platform that provides veterinary clinics with patient records, scheduling, invoicing, billing, client communication, and analytics in a fully browser-based system, headquartered in Auckland, New Zealand and acquired by IDEXX Laboratories — the global veterinary diagnostics leader — in 2021 to extend IDEXX's software platform capabilities alongside its diagnostic products. ezyVet serves more than 5,000 veterinary clinics globally with particular strength in the United States, Australia, New Zealand, and the United Kingdom.\n\nezyVet's platform provides a comprehensive clinical workflow covering patient check-in, consultation and treatment planning, prescription management, invoicing, and end-of-day reconciliation. The two-way client communication features include automated appointment reminders via SMS and email, post-visit summaries, and a client portal where pet owners can access records and request appointments. Deep integration with IDEXX's diagnostic products — including in-clinic analyzers, reference laboratory services, and imaging systems — allows results to flow directly into patient records, providing a significant competitive advantage now that IDEXX owns the platform.\n\nAs an IDEXX-owned platform, ezyVet benefits from IDEXX's global distribution network, integration with IDEXX's full diagnostics portfolio, and the ability to bundle software with diagnostic equipment and service agreements. ezyVet competes with Provet Cloud, Vetspire, Digitail, and the legacy IDEXX Cornerstone platform in the veterinary software market. IDEXX's ownership creates both an advantage (deep diagnostics integration) and a competitive consideration for clinics that use non-IDEXX diagnostic products.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.